Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER (PFE)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Cboe BZX - 07/20 06:17:46 pm
37.155 USD   -0.55%
05:11pSwiss, German drugmakers join U.S. price freeze
RE
11:40aPFIZER : At first glance
AQ
11:27aPFIZER : Initiates Pivotal Phase 3 program for Investigational Hemop..
AQ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales48 85152 82452 54654 29755 21855 609
EBITDA22 88024 23725 73622 92823 64523 827
Operating profit (EBIT)17 72318 48019 46720 78421 51222 296
Pre-Tax Profit (EBT)------
Net income7 7457 21521 30813 07714 41716 099
P/E ratio26,027,810,317,215,615,0
EPS ( $ )1,241,173,522,172,392,49
Dividend per Share ( $ )1,121,201,281,371,451,51
Yield3,47%3,69%3,53%3,65%3,88%4,05%
Reference price ( $ )32.2832.4836.2237.3637.3637.36
Announcement Date02/02/2016
11:45am
01/31/2017
11:45am
01/30/2018
11:45am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt15 68824 23623 49921 97314 68913 553
Finance------
Operating income (EBITDA)22 88024 23725 73622 92823 64523 827
Leverage
(Debt/EBITDA)
0,69x1,00x0,91x0,96x0,62x0,57x
Capital Expenditure1 3971 8231 9561 8801 8531 752
Book Value Per Share (BVPS)10,5 $9,81 $11,9 $11,6 $11,8 $12,8 $
Cash Flow per Share2,32 $2,58 $2,72 $3,25 $3,36 $3,60 $
Announcement Date02/02/2016
11:45am
01/31/2017
11:45am
01/30/2018
11:45am
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 220 295 M$ -
Entreprise Value (EV) 242 268 M$ 234 984 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 17,2x 15,6x
Capitalization / Revenue 4,06x 3,99x
EV / Revenue 4,46x 4,26x
EV / EBITDA 10,6x 9,94x
Yield (DPS / Price) 3,65% 3,88%
Price to book (Price / BVPS) 3,23x 3,18x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 38,3% 39,0%
operating Leverage (Delta EBIT / Delta Sales) 2,03x 2,06x
Net Margin (Net Profit / Revenue) 24,1% 26,1%
ROA (Net Profit / Asset) 9,49% 9,85%
ROE (Net Profit / Equities) 23,0% 23,2%
Rate of Dividend 62,8% 60,6%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   3,46% 3,36%
Cash Flow / Sales 35,0% 35,6%
Capital Intensity (Assets / Sales) 2,54x 2,65x
Financial Leverage (Net Debt / EBITDA) 0,96x 0,62x
EPS & Dividend